All Portfolio items
See full Venture&Growth portfolio
Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University. They are working with their proprietary platform to address key limitations of current gene therapy approaches to treat patients in need. The company is building a product pipeline of gene therapies targeting inherited retinal diseases and other severe genetic diseases for which there is no cure.
More Splice Bio news
Proverum is an Irish medical device company founded in 2016 as a spin-off from Trinity...
US-based MedTech company focused on treatment of heart failure applying neurostimulation.
Irish MedTech company focused on remote monitoring of heart failure patients.